Author

C. Feral

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. Altshuler· 1 shared A. Amitai-Lange· 1 shared A. Ghinet· 1 shared A. Kaganovsky· 1 shared A. Mukherjee· 1 shared B. Ryffel· 1 shared C. Delarasse· 1 shared C. Duranton· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Altshuler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Biomechanical property of limbal niche maintains stemness through YAP

S. Bhattacharya, A. Mukherjee, S. Pisano, S. Dimri, E. Knaane, A. Altshuler, W. Nasser, S. Dey, L. Shi, I. Mizrahi, O. Jokel, A. Amitai-Lange, A. Kaganovsky, M. Mimouni, S. Socea, , R. Shalom-Feuerstein

This study shows that biomechanical properties of the limbal niche regulate YAP activity, which is essential for maintaining stemness and regeneration in corneal epithelial stem cells.

bioRxiv · May 25, 2021Cell Biology

Small-molecule P2RX7 activator sensitizes tumor to immunotherapy and vaccinates mouse against tumor re-challenge

L. Douguet, S. Janho dit hreich, J. Benzaquen, l. seguin, T. Juhel, X. Dezitter, C. Duranton, B. Ryffel, J. Kanellopoulos, C. Delarasse, N. Renault, C. Furman, G. Homerin, C. Feral, J. Cherfils-Vicini, , V. Vouret-Craviari

The paper develops a P2RX7 activator that enhances immunotherapy efficacy and provides long-term tumor protection in mice.

bioRxiv · Nov 19, 2020 · PreprintCancer Biology